000 01322 a2200349 4500
005 20250516100418.0
264 0 _c20121031
008 201210s 0 0 eng d
022 _a1473-6322
024 7 _a10.1097/ACI.0b013e328355b849
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWhitaker, Paul
245 0 0 _aNonimmediate β-lactam reactions in patients with cystic fibrosis.
_h[electronic resource]
260 _bCurrent opinion in allergy and clinical immunology
_cAug 2012
300 _a369-75 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Bacterial Agents
_xadverse effects
650 0 4 _aCeftazidime
_xadverse effects
650 0 4 _aCell Proliferation
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aDesensitization, Immunologic
_xmethods
650 0 4 _aDrug Hypersensitivity
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPiperacillin
_xadverse effects
650 0 4 _aSkin Tests
_xmethods
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aNaisbitt, Dean
700 1 _aPeckham, Daniel
773 0 _tCurrent opinion in allergy and clinical immunology
_gvol. 12
_gno. 4
_gp. 369-75
856 4 0 _uhttps://doi.org/10.1097/ACI.0b013e328355b849
_zAvailable from publisher's website
999 _c21890939
_d21890939